Our results illuminated that high expression of miR-222-3p could aid PCOS diagnosis and predict the increased risk of diabetes and CDV, and miR-222-3p targeted PGC-1α and was negatively associated with PGC-1α. The gene discussed is PPARGC1A; the disease is polycystic ovary syndrome.